MedPath

Carbon monoxide

Generic Name
Carbon monoxide
Drug Type
Small Molecule
Chemical Formula
CO
CAS Number
630-08-0
Unique Ingredient Identifier
7U1EE4V452

Overview

Carbon monoxide (CO) is a colorless, odorless, and tasteless gas that has a slightly lower density than air. It is toxic to hemoglobin utilizing animals (including humans), when encountered in concentrations above about 35 ppm, although it is also formed in normal animal metabolism in low quantities, and is thought to have some normal biological/homeostatic functions . Carbon monoxide (CO), is a ubiquitous environmental product of organic combustion, which is also formed endogenously in the human body, as the byproduct of heme metabolism . Exhaled CO (eCO), similar to exhaled nitric oxide (eNO), has been evaluated as a candidate breath biomarker of pathophysiological states, including smoking status, and inflammatory diseases of the lung and other organs. Exhalation of corbon monoxide values have been studied as potential indicators of inflammation in asthma, stable COPD and exacerbations, cystic fibrosis, lung cancer, and during surgery or critical care . A test of the diffusing capacity of the lungs for carbon monoxide (DLCO), is one of the most clinically valuable tests of lung function testing. The technique was first described 100 years ago, and applied to clinical practice many years after. The DLCO measures the ability of the lungs to transfer gas from inhaled air to the red blood cells in pulmonary capillaries. The DLCO test is both convenient and simple for the patient to undergo. The ten seconds of breath-holding required for the DLCO maneuver is easier for most patients to perform than the forced exhalation required for other respiratory tests . Carbon monoxide is presently used in small amounts in low oxygen modified atmosphere packaging systems (MAP) for fresh meat to stabilize and maintain natural meat color. This use of CO has been generally recognized as safe (GRAS) in several packaging applications for fresh meat products. Since 2002, FDA has favorably reviewed three GRAS notifications for carbon monoxide use in fresh meat packaging . The FDA classifies this drug as permitted as a food additive in the packaging and preparation of food products, while following the federal code of regulations . There have been several concerns voiced of over the use of carbon monoxide in food products , , . The European Union has banned the use of carbon monoxide as a color stabilizer in meat and fish. A December 2001 report from the European Commission's Scientific Committee on Food concluded that the gas did not pose a risk provided that food was maintained adequately cold during storage and transport to prevent the growth of microorganisms . In New Zealand, the use of carbon monoxide in fish preparation has been banned, as it may mask the effects of food spoilage and bacterial growth .

Indication

Used as a marker of respiratory status in spirometry tests , . Food additive for pigment fixation in meat .

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
King Bio Inc.
57955-9001
ORAL
10 [hp_X] in 59 mL
5/19/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
LUNG DIFFUSION TEST MIXTURE
matheson gas products canada inc.
00580759
Gas - Inhalation
.5 %
12/31/1982
LUNG DIFFUSION TEST MIX NOHCO
liquid carbonic inc.
00588067
Gas - Inhalation
.3 %
12/31/1968
CARBON MONOXIDE, COMPRESSED AIR MEDICAL G.M.
Praxair Canada Inc
02014351
Gas - Inhalation
0.3 %
12/31/1993
LUNG DIFFUSION TEST MIXTURE
matheson gas products canada inc.
00580740
Gas - Inhalation
.4 %
12/31/1982
CO-HE-O2-N2 MIXTURE
02154773
Gas - Inhalation
0.3 %
12/31/1995
LUNG DIFFUSION TEST MIXTURE
matheson gas products canada inc.
00580767
Gas - Inhalation
1.5 %
12/31/1982
LUNG DIFFUSION TEST MIX NO NE CO
Praxair Canada Inc
00588075
Gas - Inhalation
0.3 %
12/30/1970
CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M.
Praxair Canada Inc
02014424
Gas - Inhalation
0.3 %
12/31/1993
HOMEOPATHIC MEDICINE (S#498) DPS 30C
total health centre
02079186
Drops - Oral
30 C / ML
12/31/1994
LUNG DIFFUSION TEST MIXTURE GAS
Praxair Canada Inc
00823066
Gas - Inhalation
0.1 %
12/30/1970

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.